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ORIGINAL ARTICLE
Association of Operator and Hospital Experience 
With Procedural Success Rates and Outcomes 
in Patients Undergoing Percutaneous Coronary 
Interventions for Chronic Total Occlusions
Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
Rami Zein , DO; Milan Seth, MS; Hussein Othman, MD; Howard S. Rosman, MD; Thomas Lalonde, MD;  
Khaldoon Alaswad, MD; Daniel Menees, MD; Edouard Daher, MD; Rajendra H. Mehta, MD, MS; Hitinder S. Gurm, MBBS
BACKGROUND: An inverse relationship has been described between procedural success and outcomes of all major cardiovascular 
procedures. However, this relationship has not been studied for percutaneous coronary intervention (PCI) of chronic total 
occlusion (CTO).
METHODS: We analyzed the data on patients enrolled in Blue Cross Blue Shield of Michigan Cardiovascular Consortium 
registry in Michigan (January 1, 2010 to March 31, 2018) to evaluate the association of operator and hospital experience 
with procedural success and outcomes of patients undergoing CTO-PCI. CTO-PCI was defined as intervention of a 100% 
occluded coronary artery presumed to be ≥3 months old.
RESULTS: Among 210 172 patients enrolled in the registry, 7389 (3.5%) CTO-PCIs were attempted with a success rate of 
53%. CTO-PCI success increased with operator experience (45% and 65% in the lowest and highest experience tertiles) and 
was the highest for highly experienced operators at higher experience centers and the lowest for inexperienced operators 
at low experience hospitals. Multivariable logistic regression models (with spline transformed prior operator and institutional 
experience) demonstrated a positive relationship between prior operator and site experience and procedural success rates 
(likelihood ratio test=141.12, df=15, P<0.001) but no relationship between operator and site experience and major adverse 
cardiac event (likelihood ratio test=19.12, df=15, P=0.208).
CONCLUSIONS: Operator and hospital CTO-PCI experiences were directly related to procedural success but were not related 
to major adverse cardiac event among patients undergoing CTO-PCIs. Inexperienced operators at high experience centers 
had significantly higher success but not major adverse cardiac event rates compared with inexperienced operators at low 
experience centers. These data suggested that CTO-PCI safety and success could potentially be improved by selective 
referral of these procedures to experienced operators working at highly experienced centers.
GRAPHIC ABSTRACT: A graphic abstract is available for this article.
Key Words: Japan ◼ length of stay ◼ logistic models ◼ percutaneous coronary intervention ◼ publication
See Editorial by  Kaul and Kandzari
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Many studies have evaluated the relationship between procedural volume of operators and hos-pitals with outcomes for many invasive procedures 
supporting the “practice makes perfect” belief.1–5 These 
investigations have demonstrated lower rates of in-hos-
pital complications including mortality and shorter length 
of stay of these procedures when performed at high vol-
ume centers.1–5 The inverse relationship between volume 
and adverse outcome has been more pronounced par-
ticularly for patients with high-predicted risk for a given 
procedure and among those undergoing more complex 
procedures.1–7
The proportion of patients undergoing percutane-
ous coronary intervention (PCI) of chronic total occlu-
sions (CTO) has been increasing over the last decade.8 
CTO-PCI continues to be challenging and complex as 
evidenced by its lower success rate and worse out-
comes compared with non-CTO-PCI.8–10 More care-
ful patient selection, technological improvements, and 
evolving techniques have all contributed to improving 
procedure success rates and reduced complications.11 
A recent publication of the Japanese CTO-PCI expert 
registry reported that 41 most experienced operators 
had a very high overall technical success rate of 89.9% 
almost mirroring those observed among patients 
undergoing non-CTO-PCIs suggesting that success 
rates and outcomes are likely to be better in experi-
enced hands.12 This has led some experts to think that 
the path to attaining proficiency in CTO interventions is 
lengthy and may need up to 300 such procedures.13,14 
Although operator and institutional volume for this 
procedure varies in community centers, the majority 
of operators and hospitals in United States perform 
very few CTO-PCIs per year.1 Thus, the association of 
operator and hospital experience of CTO-PCI with pro-
cedural success and outcomes in contemporary clinical 
practice remains of great interest, albeit poorly stud-
ied. The purpose of this investigation is to study the 
relationship of operator and hospital experience with 
procedural success rates and outcomes of CTO-PCI 
using data on patients enrolled in the in Blue Cross 
Blue Shield of Michigan Cardiovascular Consortium 
(BMC2) registry in Michigan.15
METHODS
Study Population and Data Collection
The study population consisted of consecutive patients who 
underwent PCI between January 1, 2010 and March 2018 
at all nonfederal hospitals in Michigan that participate in the 
quality improvement registry, the BMC2. Details of BMC2 reg-
istry have been previously described.15 All patients who under-
went PCI and whose data were collected in the registry during 
the study time frame were included in this analysis. Patients 
were excluded if they underwent PCI for ST-segment–eleva-
tion myocardial infarction or in cases where a valid National 
Provider Identifier number was not recorded for the operator. 
Data were collected by onsite registered nurse coordinators on 
demographic and clinical characteristics, procedural details and 
outcomes of patients undergoing PCI procedures and submit-
ted electronically to the registry. Data quality and the inclusion 
of consecutive procedures were ensured by ad hoc queries, 
random chart reviews, and a series of diagnostic routines 
included in the database.15 The registry has been approved or 
the need for approval waived by the institutional review board 
of each participating hospital. The authors are unable to share 
the data due to the nature of contractual obligations with par-
ticipating hospitals; the analysis code is available on request 
from Milan Seth (mcseth@med.umich.edu).
Data Definitions and Outcome Measures
CTO was defined as 100% luminal diameter stenosis with the 
absence of antegrade flow, with the duration being known or 
assumed to be ≥3 months. Procedural success was defined as 
<50% angiographic stenosis with Thrombolysis in Myocardial 
Infarction flow grade 3 after the procedure without any major 
adverse cardiac event (MACE). MACE was defined as the com-
posite of death, urgent coronary artery bypass graft surgery, 
stroke, or tamponade. Bleeding was defined as any bleeding 
associated with one of the following: hemoglobin drops of ≥3 
g/dL, transfusion of whole blood or packed red blood cells or 
procedural intervention/surgery at the bleeding site to reverse, 
stop or correct the bleeding. Vascular complication was defined 
Nonstandard Abbreviations and Acronyms
BMC2  Blue Cross Blue Shield of Michigan 
Cardiovascular Consortium
CTO chronic total occlusion
MACE major adverse cardiac event
PCI percutaneous coronary intervention
WHAT IS KNOWN
• Chronic total occlusion (CTO)-percutaneous coro-
nary intervention (PCI) is challenging and complex 
as demonstrated by its lower success rate and 
worse outcomes compared with non-CTO-PCI.
WHAT THE STUDY ADDS
• A real-world insight on CTO-PCI experience of 
everyday operators in the state of Michigan.
• Operator and hospital CTO-PCI experiences were 
directly related to procedural success but were 
not related to major adverse cardiac event among 
patients undergoing CTO-PCIs.
• Compared with lesser experienced CTO operators, 
more experienced operators performed CTO PCI 
on those with baseline characteristics associated 
with much higher risk of adverse outcomes.
• Low experience operators at high experience cen-
ters had higher procedure success.
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as any of the following: pseudoaneurysm, arteriovenous fistula, 
femoral neuropathy, retroperitoneal hematoma, hematoma at 
the access site requiring transfusion/prolonged hospital stay 
or causing a drop-in hemoglobin ≥3.0 g/dL, or any access site 
complication requiring surgical repair. In-hospital mortality was 
defined as all-cause death from either cardiac or noncardiac 
etiology. Contrast-induced nephropathy was defined as impair-
ment in renal function resulting in 0.5 mg/dL absolute increase 
in serum creatinine from baseline.16
Statistical Methods
For display purposes, patients were divided into 3 tertiles 
based on operator CTO-PCI experience. For each procedure, 
the number of prior procedures performed by the operator 
occurring previously in the registry was calculated. Tertiles 
were then determined based on these prior procedure counts, 
and procedures were grouped by the prior experience of 
the operator at that point in time, so that the same operator 
could have (and likely will have) performed procedures in all 
3 tertiles. Demographics baseline characteristics, treatments, 
cardiac catheterization and PCI procedural details, and in-
hospital outcomes were compared among these groups using 
Pearson χ2 test for categorical variables and ANOVA for con-
tinuous variables. Missing data were not defaulted to nega-
tive and denominators reflect cases reported. As of the date 
of each CTO-PCI procedure, the total number of CTO cases 
performed (1) at the hospital where the PCI was performed 
and (2) by the operator performing PCI between January 1, 
2010 and the date of the procedure was determined. These 
values for site and operator experience at the time of each 
case were then used for regression modeling to determine 
the relationship between experience and outcomes and to 
partition cases into tertiles of site and operator experience. 
Multivariable logistic regression analyses were performed to 
adjust for patient risk factors including CAD presentation, PCI 
status, age, sex, and baseline BMC2 predicted risks of death 
and transfusion17 while evaluating the impact of basis spline 
transformed hospital and operator experiences and their 
interactions upon procedural success rates and outcomes. As 
a sensitivity analysis, simplified regression models adjusting 
only for baseline predicted risk and operator prior CTO experi-
ence were fitted to the data. Mean predicted baseline risk 
estimates, procedural success, and in-hospital mortality was 
aggregated by prior CTO operator experience, and weighted 
spline linear regression models were fitted to these data. 
Model predicted outcome rates by prior CTO experience were 
then plotted to assess potential threshold values for operator 
experience associated with performance. Operator and insti-
tutional prior experience variables were transformed using a 
basis matrix representing the family of cubic piecewise poly-
nomials. The results of these models are provided graphically 
in 3-dimensional perspective plots. Likelihood ratio tests were 
utilized to assess if prior operator and institutional CTO expe-
rience (and their interactions) were independently associated 
with procedural success and in-hospital death and MACE 
after adjustment for baseline clinical and demographic vari-
ables. All tests were 2-sided, and P<0.05 was considered 
statistically significant. All analyses were performed using R 
software (version 3.4.1, R Core Team [2017]. R: A language 
and environment for statistical computing. R Foundation for 
Statistical Computing, Vienna, Austria. URL https://www.R-
project.org/) by the University of Michigan (Ann Arbor, MI).
RESULTS
Baseline Demographics, History, Clinical 
Presentation, and Laboratory Features in 3 
Tertiles Based on Experience of Operator CTO 
Procedures
During the 8-year study period, a total of 7389 CTO-
PCI (3.4%) were recorded among a total of 210 172 
PCI procedures at 46 sites with the proportion of CTO-
PCI among all PCI procedures increasing over the study 
period (2.7% in 2010 to 4.5% in 2017; Table 1). Operator 
experiences in the 3 tertiles were divided <12, 12 to 33, 
and 34 or more previous CTO-PCI at the time of CTO-
PCI. Operator experience ranged widely over the study 
period (median [interquartile range]: 12 (5–23), min=1, 
max=334) with few operators performing >50 CTO 
procedures during the study period (n=30/337, 8.9%) 
and most operators performing 20 to 50 (n=83/337, 
24.6%) and <20 (n=224/337, 66.5%) CTO procedures 
during the study period. Similarly, few institutions per-
formed >50 CTO PCI/y (n=4; 8.7%) with most institu-
tions performing 20 to 50 CTO-PCIs per year (n=10, 
21.7%) or <20 PCIs per year (n=32, 69.6%). Proportion 
of institutions performing >50 CTO per year was 8.7% in 
2010 and 13.0% in 2017. Compared with patients in the 
lower operator experience tertiles, those in the highest 
tertile group were at high-risk with older age and greater 
prevalence of history of hypertension, diabetes mellitus, 
myocardial infarction, congestive heart failure, coronary 
artery bypass graft, or PCI, peripheral vascular disease 
as well as lower glomerular filtration rate at presentation.
Pre- and Intraprocedural Treatments in 3 
Tertiles Based on Experience of Operator CTO 
Procedures
The operators with the most experience were more likely 
to perform CTO-PCI in patients with stable symptoms 
compared with the lower operator experience tertiles 
(29% versus 18%; Table 2). Stress testing before CTO-
PCI was performed in similar proportion of patients in the 
3-operator experience tertiles cohorts.
Procedural Details in 3 Tertiles Based on 
Experience of Operator CTO Procedures
The highest experience tertile operated most frequently 
on the right coronary artery along with the left anterior 
descending coronary artery (Table 3). The average fluo-
roscopy time was longest in the highest operator expe-
rience tertile and paralleled higher amount of contrast 
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use and radiation dose compared with those in the lower 
operator experience tertiles.
Procedural Outcomes
Overall procedural success improved from 45% in 2010 
to 55% to 2017 (Table 4; Figures 1 through 3). Proce-
dural success for CTO-PCI was significantly higher when 
performed by high-compared with low experience opera-
tors (Tertile 3: 65%, Tertile 2: 54.5%, Tertile 1: 44.9%, 
P<0.0001; Figure 1). A similar relationship was also 
observed between institutional experience and the suc-
cess rates for CTO-PCI. The success rates of CTO-PCI 
among low experience operators at highly experienced 
centers were higher than those performed by low experi-
ence operators at low experience centers (Figure 1). The 
highest success rates were observed for highly experi-
enced operators at high-experience centers and lowest 
for low experience operators at low experience centers.
Observed major adverse events and death were higher 
in low experience compared with intermediate experi-
ence operators tertile (4.0% versus 2.9%) but similar 
to that seen in the highest experience tertile operators 
(MACE 4.0% versus 3.2%). In-hospital mortality showed 
a similar pattern (1.8%, 0.8%, and 1.7% low, intermediate 
and highly experienced tertiles, P=0.0039 and 0.8081 
for low versus intermediate and high experience opera-
tor tertiles, respectively). In the periprocedural period, 
the highest experience tertile operators had the lowest 
risk of need for coronary artery bypass graft and repeat 
PCI, whereas the incidence of cardiac tamponade, major 
bleeding, need for transfusion, myocardial infarction, car-
diogenic shock, and stroke were significantly higher in 
this group compared with the lowest and mid experience 
tertiles. Mechanical circulatory support devices were used 
more frequently in the highest experience tertile opera-
tors. Length of hospitalization was the highest in the low 
experienced operators compared with intermediate and 
high experienced operators (2.74±3.66, 2.58±3.68, and 
2.52 ±3.66 days, respectively). The overall rate of MACE 
did not change over the study period.
Multivariable Logistic Regression Models
Multivariable logistic regression models (with spline 
transformed prior operator and institutional experience) 
displayed a positive relationship indicating inexperi-
enced operators at high experience centers had sig-
nificantly higher success (likelihood ratio test=141.12, 
df=15, P<0.001; Figure 1) and an inverse relationship 
between operator and site experience and mortality 
(likelihood ratio test=27.69, df=15, P=0.023; Figure 2). 
Table 1. Demographics, Medical History, and Laboratory Features in 3 Tertiles Based on Operator CTO-PCI Experience
Variables
First Tertile N=2336 
(<12 CTO-PCI)
Second Tertile N=2144 
(12-33 CTO-PCI)
Third tertile N=2178 
(>34 CTO-PCI)
T1 vs T2 
(P-Value)
T1 vs T3 
(P-Value)
T2 vs T3 
(P-Value)
Demographic characteristics
 Age, y 62.9±11.4 63.7±11.2 64.3±10.9 P=0.030 P<0.001 P=0.061
 Male 72.6% 73.4% 75.0% P=0.563 P=0.075 P=0.240
 White race 81.8% 83.7% 82.4% P=0.091 P=0.596 P=0.253
Medical history
 Body mass index, kg/m2 31.1±7.6 31.3±6.9 31.2±6.7 P=0.339 P=0.673 P=0.572
 Hypertension 86.1% 88.9% 91.0% P=0.005 P<0.001 P=0.019
 Dyslipidemia 86.1% 88.9% 91.0% P=0.125 P<0.001 P<0.001
 Diabetes mellitus 40.6% 41.9% 46.0% P=0.369 P<0.001 P=0.007
 Current smoking 31.6% 29.3% 26.8% P=0.097 P<0.001 P=0.065
 Previous MI 40.5% 41.8% 52.0% P=0.379 P<0.001 P<0.001
  Prior percutaneous coronary  
intervention
45.5% 53.6% 67.4% P<0.001 P<0.001 P<0.001
 Prior coronary artery bypass 13.0% 16.1% 24.7% P=0.004 P<0.001 P<0.001
 Cerebrovascular disease 13.5% 13.7% 16.8% P=0.859 P=0.002 P=0.004
 Peripheral arterial disease 14.7% 16.6% 21.1% P=0.077 P<0.001 P<0.001
 Chronic lung disease 18.8% 22.1% 20.2% P=0.005 P=0.233 P=0.116
 Prior heart failure 18.8% 21.2% 31.5% P=0.043 P<0.001 P<0.001
Laboratory
 Hemoglobin, gm/dL 13.5±1.9 13.5±1.9 13.4±1.9 P=0.601 P=0.032 P=0.111
  Glomerular filtration rate ml/min  
per 1.732
76.8±24.7 76.9±24.2 74.2±24.9 P=0.907 P<0.001 P<0.001
Value presented as percentages unless specified otherwise. CTO indicates chronic total occlusion; MI, myocardial infarction; and PCI, percutaneous coronary 
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In contrast, no statistically significant independent 
relationship was observed between operator and site 
experience with MACE (likelihood ratio test=19.12, 
df=15, P=0.208; Figure 3). (The regression models 
are further described in the Data Supplement  with 
additional figures [Figures I and II in the Data Supple-
ment] for predicted procedural success and predicted 
in-hospital mortality based on operator CTO experience, 
respectively.)
DISCUSSION
Our study of contemporary clinical practice in Michi-
gan showed that CTO-PCI experience varied widely 
by operator and across institutions. Few institutions 
or operators performed >50 CTO-PCIs per year. Our 
analysis showed that procedural success for CTO-PCI 
was directly related to procedural experience both at 
operator and institutional levels with higher experience 
associated with greater procedural success. Additionally, 
more experienced operators were more likely to perform 
CTO-PCI in higher-risk and thus had higher incidence of 
in-hospital complications including higher incidence of 
cardiac tamponade, major bleeding, need for transfusion, 
myocardial infarction, cardiogenic shock, and stroke. 
Nonetheless, the need to repeat revascularization with 
either PCI or coronary artery bypass graft was lower in 
the experienced operators. Observed in-hospital mortal-
ity was similar with highly experienced compared with 
less experienced operators but demonstrated statisti-
cally significant (but clinically marginal) inverse relation-
ship with operator experience once adjusted for baseline 
confounders. A statistically significant (but clinically 
marginal) inverse relationship was also demonstrated 
for individual site experience where more experienced 
sites had lower adjusted in-hospital death compared 
with inexperienced institutions. Additionally, in-hospital 
rates of death for CTO-PCI were the lowest among high 
experience operators at high-experienced centers and 
highest for low experience operators at inexperienced 
centers. Low experience operators at highly experi-
enced centers have lower death rates compared with 
Table 2. Preprocedural Presentation and Intraprocedural Treatments in 3 Tertiles Based on Operator CTO-PCI Experience
Presentation and Preprocedural Testing
First Tertile (<12 
CTO-PCI)
Second Tertile 
(12–33 CTO-PCI)
Third Tertile (>34 
CTO-PCI)
T1 vs T2  
(P Value)
T1 vs T3  
(P Value)
T2 vs T3  
(P Value)
Patient symptom presentation
 Symptom unlikely to be ischemic 2.8% 3.3% 3.1% P=0.345 P=0.500 P=0.789
 Stable angina 18.7% 20.8% 29.1% P=0.085 P<0.001 P<0.001
 Unstable angina 44.0% 49.0% 48.9% P=0.001 P=0.001 P=0.960
 Non–ST-segment–elevation myocardial 
infarction
28.3% 21.6% 13.4% P<0.001 P<0.001 P<0.001
Anginal classification within 2 wks
 No symptoms 6.1% 5.4% 5.5% P=0.277 P=0.345 P=0.885
 Canadian cardiovascular society I 2.6% 2.5% 1.5% P=0.909 P=0.013 P=0.019
 Canadian cardiovascular society II 13.6% 12.9% 11.6% P=0.535 P=0.046 P=0.178
 Canadian cardiovascular society III 46.3% 51.0% 58.6% P=0.002 P<0.001 P<0.001
 Canadian cardiovascular society IV 27.0% 24.3% 18.8% P=0.038 P<0.001 P<0.001
  Cardiomyopathy or left ventricular systolic 
dysfunction
15.4% 16.5% 20.3% P=0.316 P<0.001 P=0.001
Preoperative evaluation
 Stress or imaging studies 47.1% 46.1% 45.7% P=0.500 P=0.343 P=0.791
 Diagnostic cath 86.3% 80.8% 70.8% P<0.001 P<0.001 P<0.001
Procedural medications
 Bivalirudin 24.9% 18.7% 2.7% P<0.0001 P<0.0001 P<10.000
 Aspirin (any) 97.5% 98.7% 99.6% P=0.0020 P<0.0001 P=0.0022
 GP IIb/IIIa (any) 21.2% 15.2% 8.6% P<0.0001 P<0.0001 P<0.0001
 Low molecular weight heparin (any) 3.3% 2.24% 0.7% P=0.0259 P<0.0001 P<0.0001
 Prasugrel 11.6% 10.5% 6.3% P=0.2508 P<0.0001 P<0.0001
 Clopidogrel 58.5% 59% 67.7% P=0.7499 P<0.0001 P<0.0001
 Unfractionated heparin (any) 85.5% 89.1% 98.6% P=0.0003 P<0.0001 P<0.0001
 Ticagrelor 13.3% 19.6% 20.5% P<0.0001 P<0.0001 P=0.4725
These findings exclude patients with documented contraindications to the medications listed, where medication use was blinded as part of a clinical trial, or at time-
points where the medication was not an option available to the abstractor (eg, Ticagrelor was not added to the registry treatment list until after approval in Q1 2012). 
Value presented as percentages unless specified otherwise. CTO indicates chronic total occlusion; and PCI, percutaneous coronary intervention.
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low experience operators at low experience centers. No 
independent relationship was observed for operator and 
site experience with adjusted MACE.
Few studies have focused specifically on examin-
ing the volume outcomes relationship for CTO-PCI.18,19 
Thompson et al18 evaluated 636 patients between 2005 
and 2008 undergoing CTO-PCI and showed that pro-
cedural success rate was higher among high volume 
operators (defined as >75 antegrade and >20 retro-
grade CTOs) than low volume operators (59.8% versus 
75.2%, P<0.0001). No differences were observed in the 
2 groups in the in-hospital adverse event rates. Brilakis 
et al8 examined outcomes of CTO-PCI among 22 365 
patients with stable angina enrolled in National Cardio-
vascular Data Registry between 2009 and 2013. Proce-
dural success rates were significantly higher in operators 
performing >10 CTO-PCI per year (74.5%) compared 
with those performing 5 to 10 (62.1%) and <5 (58.5%) 
CTO-PCI per year (P<0.001).
Our data were consistent with the findings of the 
above studies confirming the direct relationship of 
CTO-operator and site procedural experience with 
success rate of PCI. Furthermore, our study provided 
insights into the relationship for CTO-PCI experiences 
with outcomes at both operator and institutional levels 
reaffirming that similar inverse relationship existed at 
both these levels and the highest procedural success 
rates and lowest mortality were observed when CTO-
PCI were performed by high experience operators and 
highly experienced institutions.
More importantly, our investigation further revealed 
that low experience operators at highly experienced cen-
ters had significantly better outcomes than low experi-
ence operators at low experience hospitals. Thus, the 
Table 3. Vessel Statistics and Procedural Details in 3 Tertiles Based on Experience of Operator CTO Experience
First Tertile (<12 
CTO-PCI)
Second Tertile 
(12–33 CTO-PCI)
Third Tertile  
(>34 CTO-PCI)
T1 vs T2  
(P Value)
T1 vs T3  
(P Value)
T2 vs T3  
(P Value)
Percutaneous coronary intervention target vessel
 Left main 0.81% 0.65% 1.88% P=0.5306 P=0.0017 P=0.0003
 Left anterior descending 30.4% 29.7% 28.3% P=0.5967 P=0.1204 P=0.3168
 Left circumflex 27% 25% 23.1% P=0.1158 P=0.0030 P=0.1741
 Right coronary artery 42.3% 45.6% 50.7% P=0.0251 P<0.001 P=0.0009
 Lesion location data missing 0.9% 0.42% 0.69% P=0.0495 P=0.4274 P=0.2342
Coronary arteries with stenosis >50%
 1 vessel 39.8% 41.3% 43.1% P=0.3179 P=0.0265 P=0.2337
 2 vessels 32.2% 32.7% 29.9% P=0.6941 P=0.1090 P=0.0504
 3 vessels 28.0% 25.9% 26.9% P=0.1289 P=0.4319 P=0.4690
Pre-PCI TIMI flow
 TIMI—0 89.2% 90.7% 91.1% P=0.1052 P=0.0344 P=0.6306
 TIMI—1 4.5% 3.9% 3.8% P=0.3038 P=0.2231 P=0.8551
 TIMI—2 1.5% 1.6% 2.2% P=0.7175 P=0.0779 P=0.1712
 TIMI—3 2.6% 2.6% 1.7% P=0.9989 P=0.0355 P=0.0386
 Not available 2.2% 1.3% 1.8% P=0.0202 P=0.3548 P=0.1611
Post-PCI TIMI flow
 TIMI—0 8.0% 8.5% 7.1% P=0.5195 P=0.2352 P=0.0726
 TIMI—1 1.3% 1.2% 0.8% P=0.8295 P=0.1340 P=0.2060
 TIMI—2 1.8% 1.6% 2.6% P=0.7508 P=0.0471 P=0.0249
 TIMI—3 47.8% 57.9% 68.3% P<0.0001 P<0.0001 P<0.0001
  NA (primarily due to unsuccessful guidewire 
crossing)
41.5% 31.4% 22.7% P<0.0001 P<0.0001 P<0.0001
 Fluoroscopy time, min 26.5±18.1 30.8±23.2 43.2±31.11 P<0.001 P<0.001 P<0.001
 Radiation dose, mGy 2476±2364.5 2463.9±1801.4 2918±2104.9 P=0.923 P<0.001 P<0.001
 Contrast volume, mL 207.7±91.5 206.2±97.5 212.4±98.4 P=0.617 P=0.096 P=0.040
Access site
 Femoral 72.6% 69.9% 72.1% P=0.046 P=0.697 P=0.114
 Brachial 0.2% 0.3% 0.1% P=0.656 P=0.297 P=0.150
 Radial 27.2% 29.8% 27.7% P=0.055 P=0.680 P=0.139
Value presented as percentages unless specified otherwise. CTO indicates chronic total occlusion; PCI, percutaneous coronary intervention; and TIMI, Thrombolysis 
in Myocardial Infarction.
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highest success rates and lowest incidence of death 
were observed among patients undergoing CTO-PCI 
by highly experienced operators at highly experienced 
centers and lowest success rates and highest death for 
those undergoing CTO-PCI by least experienced opera-
tors at low experience centers. These findings are com-
parable to those observed in a study by Fanaroff et al1 
who examined volume relationship for patients undergo-
ing any PCI using data from the ACC National Cardio-
vascular Data Registry.
The higher incidence of in-hospital complications 
among patients treated by experienced operators and 
sites is probably related to both, a greater likelihood of 
attempting higher risk cases and to use more aggres-
sive techniques, thus resulting in more MIs and/or more 
bleeding and tamponade secondary to coronary perfora-
tion. However, the fact that more experienced operators 
had less emergent open-heart surgeries, repeat PCIs, 
as well as the lowest length of hospital stay and lower 
risk adjusted mortality suggests that these complica-
tions were managed expeditiously and more effectively 
by these operators, perhaps accounting for lower in-
hospital death rates despite higher MACE rates. Need-
less to say, these data highlight that CTO-PCI even in the 
most experienced hands is associated with higher risk of 
adverse events and the decision to proceed needs to be 
Table 4. Procedural Outcomes in 3 Tertiles Based on Operator CTO-PCI Experience
Variable
First Tertile 
(<12 CTO-PCI)
Second Tertile 
(12–33 CTO-PCI)
Third Tertile 
(>34 CTO-PCI)
T1 vs T2  
(P Value)
T1 vs T3 
(P Value)
T2 vs T3 
(P Value)
Procedural success 44.9% 54.5% 64.5% P<0.0001 P<0.0001 P<0.0001
Major adverse cardiac event 4% 2.9% 3.2% P=0.0369 P=0.1666 P=0.4795
Death 1.8% 0.8% 1.7% P=0.0039 P=0.8081 P=0.0085
Urgent coronary artery bypass surgery 1.8% 1.6% 0.3% P=0.6590 P<0.0001 P<0.0001
Stroke 0.4% 0.2% 0.6% P=0.2168 P=0.3082 P=0.0313
Tamponade 0.3% 0.3% 1% P=0.6650 P=0.0021 P=0.0090
Myocardial infarction 1.7% 2.2% 3.5% P=0.2035 P<0.0001 P=0.0082
Repeat percutaneous coronary intervention 1.1% 0.5% 0.3% P=0.0425 P=0.0049 P=0.3476
Bleeding 2.9% 4% 7.3% P=0.0353 P<0.0001 P<0.0001
Transfusion 2.2% 2.9% 4.1% P=0.1326 P=0.0003 P=0.0408
Contrast-induced nephropathy 3.4% 2.9% 3.7% P=0.3953 P=0.5717 P=0.1630
Intraaortic balloon pump 2.0% 1.3% 1.9% P=0.082 P=0.919 P=0.105
Other mechanical ventricular support 1.4% 1.5% 5.7% P=0.727 P<0.001 P<0.001
Cardiogenic shock w/in 24 h 1.9% 1.4% 2.8% P=0.097 P=0.999 P=0.102
Cardiac arrest w/in 24 h 1.5% 0.5% 0.5% P=0.001 P<0.001 P=0.971
Hospital length of stay 2.74±3.66 d 2.58±3.68 d 2.52±3.66 d P=0.0008 P<0.0001 P=0.1127
CTO indicates chronic total occlusion; and PCI, percutaneous coronary intervention.
Figure 1. Association of operator and hospital chronic total 
occlusion (CTO)-percutaneous coronary intervention (PCI) 
experience with CTO-PCI procedural success rates.
Figure 2. Association of operator and hospital experience 
with in-hospital mortality after chronic total occlusion (CTO)-
percutaneous coronary intervention.
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individualized for each patient after careful discussion of 
risks versus benefits.
Programs specializing in treating chronic total occlu-
sions are growing rapidly across the globe resulting 
in exponential growth in the number of interventional 
cardiologists tackling these lesions and in the number 
of CTO-PCI. However, CTO-PCI is challenging both in 
terms of complexities requiring availability of technol-
ogy specific to CTO-PCI as well as commitment both at 
operator and institutional levels for improving procedural 
success. The lower success rates and associated worse 
outcomes for CTO-PCI by low experience operators or at 
low experience sites calls for understanding of the rea-
sons behind such inferior outcomes. Potentially remedial 
factors include adequate formal training for the proce-
dure (including that for retrograde approach) and recog-
nition and management of its complications as well as 
institutional commitment to provide technology that aid 
in performing these procedures successfully and safely. 
The availability of CTO-PCI enabling technology20 and 
use of retrograde approach for recanalization of CTO18 
have been shown to improve procedural success. The 
findings of previous investigators and our study further 
suggest that procedural success is likely greater when 
CTO-PCI is performed by more experienced operators 
at high experience centers. This would support region-
alization of CTO-PCI to few highly experienced opera-
tors at highly experienced sites, but this approach may 
be impractical for many US health care segments given 
local referring and practice patterns.
The finding in our study that inexperienced operators 
at high experience sites had better outcomes than those 
at inexperienced centers may suggest that oversight of 
CTO-PCI performed by inexperienced operators by more 
experienced operators may have the potential for improv-
ing procedural success and outcomes. This hypothesis is 
supported by a study by Eggebrecht et al21 that used data 
from the German Quality Assurance Registry on Aortic 
Valve Replacement showed that supervision by a Heart 
team from centers with on-site cardiac surgery of TAVR 
procedures at low experienced sites without cardiac sur-
gery resulted in similar rates of deaths and stroke at these 
sites compared with that observed at highly experienced 
institutions with on-site cardiac surgery programs.
Limitations
Some limitations should be considered when interpreting 
the current study. Given observational nonrandomized 
nature of this analysis, caution needs to be exercised 
when inferring causality. As in all observational analyses, 
influence of unmeasured confounders on study results 
cannot be ascertained. Given minority of patients get-
ting functional studies before an intervention on a CTO, 
whether the procedures were appropriate or underuti-
lized could not be determined. Specifically, we are unable 
to provide insight into the proportion of patients who were 
on optimal guideline-based medical therapy before CTO-
PCI, reasons for performing (or not) stress test in patients 
and its results (positive or negative) including the extent 
of ischemia that went into decision making. The defini-
tion of CTO was based on the operator’s perception of 
whether or not the occlusion was >3 months older or not. 
We cannot ascertain the differences across operators or 
institutions in specific differences in anatomic adversities 
in patient undergoing CTO interventions such as coro-
nary anatomy (for example, calcification or side branch at 
the site of occlusion or the Castle score22) or use of lim-
ited technique (such as antegrade approach rather than 
additional attempts using a retrograde approach). The 
registry collects data on in-hospital outcomes only and 
precluding us from providing any insight into the asso-
ciation of CTO-interventions with improvement of quality 
of life.
Conclusions
Operator and hospital CTO-PCI experiences were 
directly related to procedural success but were not 
related to MACE among patients undergoing CTO-
PCIs. Low experience operators at high experience cen-
ters had significantly higher procedure success but not 
MACE rates compared with low experience operators at 
inexperienced centers.
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Figure 3. Association of operator and hospital experience 
with in-hospital major adverse cardiac event (MACE) after 
chronic total occlusion (CTO)-percutaneous coronary 
intervention.
Multivariable logistic regression failed to identify any statistically 
significant relationship between operator and hospital experience 
with in-hospital MACE.
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